Canadian Cancer Trials Group Bulletins

Trial Management Group

Trial Activation

The Canadian Cancer Trials Group is pleased to announce that SC.23: A Randomized Phase III Double-Blind Study of Dexamethasone versus Placebo in the Prophylaxis of Radiation-Induced Pain Flare following Palliative Radiotherapy for Bone Metastases -- was centrally activated 22 November 2010.

For more information, please go to the trial-specific website at